Clinical Trial Update: A Phase I Study of SIM0388 in Participants With Malignant Ascites. [Phase 1]

View source ↗

Summary

This is a Phase I clinical trial evaluating SIM0388 in participants with malignant ascites; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Ascites

Drugs mentioned

• SIM0388

Snippet

Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. | Conditions: Malignant Ascites | Phase 1 | Status: RECRUITING